Understanding how much healthcare professionals (HCPs) know about medication can help in devising strategies to improve rational medication use. This study aimed to synthesize information on the level of medication knowledge of HCPs in Africa.
Introduction
Medication knowledge encompasses the understanding of (clinical) pharmacology and therapeutics and the skills to apply that knowledge in daily practice [1] [2] [3] . According to the European Association of Clinical Pharmacology and Therapeutics, the basic elements are 'sufficient knowledge of commonly prescribed medications, the ability to adequately treat the most common diseases, a rational approach to medication selection, and the ability to write a prescription safely and unambiguously' [4] . In a conceptual framework model for knowledge, attitude and practice [5] , rational prescribing is determined by attitude to apply specific medication knowledge to a clinical situation and the healthcare professional's prescribing skills. An adequate level of knowledge is the starting point for rational medication use. There is, however, no universally accepted level of medication knowledge physicians and other healthcare professionals responsible for prescribing, dispensing and administering medication need to have. In Norway, Simonsen et al. used a 60% of correct answers as the pass mark for nurses with regard to medication knowledge [3, 6] , and a higher threshold (80-90%) was used in a study that involved final year medical students from 15 European countries [4] .
In Africa, there is a strong need for appropriate and efficient use of scarcely available medicines; over 50% of the population in the region does not have access to essential medicines [7, 8] . Healthcare professionals (HCPs) are the principal source of information for patients. Other sources of information (patient information leaflet, drug information centres and internet) are much less accessible or affordable, and many patients are illiterate [7, 9] . The medication knowledge source for HCPs in Africa is mainly through (clinical) pharmacology courses during their under-and postgraduate training. Often a single course is given to non-pharmacy professionals, and delivered before the start of major professional courses. This situation emphasizes an important need for good medication knowledge of HCPs in Africa, but also the need for rational prescribing skills and attitudes. Understanding the level of medication knowledge can help to identify gaps and serve as the basis for focused knowledge improvement plans by policy makers and training institutes. Studies on medication knowledge in Africa are mostly limited in size and the scope of papers is usually on overall disease management not just medication [8, [10] [11] [12] . However, many studies seem to indicate that there is a lack of medication knowledge among HCPs. We performed a systematic literature review to provide a comprehensive overview of the level of medication knowledge among HCPs in Africa and to identify specific gaps in medication knowledge. We explored medication knowledge across subgroups of special interest, such as HCP specialism, and disease group.
Method

Search strategy
Following the PRISMA guidelines [13] , we performed a systematic literature search in Embase and PubMed that collectively cover a wide range of journals covering the relevant literature. Search terms were grouped into four queries, using the Boolean operators, 'or' [within a query], 'and' [between the four main queries]; Africa with list of countries, type of HCPs, knowledge and medication terms (Table S1 ). Studies published in a five-year time span from January 1, 2012 to December 31, 2016 were included to capture studies reflecting the current level of HCPs' medication knowledge. Studies were included without language restrictions.
Eligibility criteria
We included original research articles that evaluated HCPs' medication knowledge using a quantitative survey/score in Africa. Medication knowledge was defined as outlined in the introduction [1] [2] [3] . We excluded reviews, opinion pieces, letter to editors, conference abstracts and commentaries. We also excluded papers on traditional medicine and substance abuse.
Study selection and data extraction
Embase and PubMed search results were combined and duplicates removed. Titles were independently screened by D.F.B. and P.G.M. and all potentially relevant papers were selected for abstract review. These abstracts were screened by D.F.B. and double-checked by P.G.M. Full text screening was performed by D.F.B. and P.G.M. D.F.B. abstracted data using a customized electronic case report form. P.G.M. independently cross-checked the abstraction. Any differences in article screening, selection and data abstraction (specifically also in the identification of medication-related knowledge questions) were resolved in consensus between P.M., D.F.B. and, where needed. K.T. From each article, we extracted the following study characteristics: type (profession) of HCPs, sample size, country where the study was performed, the main disease focus, if the questions focused on benefits and/or harms of medications, and finally we assessed the quality of the included papers. Differences were resolved by consensus (D.F.B., P.G.M., K.T.).
We included HCPs who have had formal professional training in any healthcare field, and classified them into physicians, pharmacists, nurses/midwifes, and 'other HCPs'. The 'other HCPs' group consisted of druggists/pharmacy technicians, nurse assistants/vocational nurses, or physiotherapists. For studies that also involved patients or non-HCPs, such as community healthcare workers, we extracted medication knowledge only for the HCPs. Based on the medication knowledge questions, papers were classified into four main disease categories, namely communicable diseases (CDs), noncommunicable diseases (NCDs), family planning or gynaecological indications (FP/Gyn), or 'no specific disease focus'. Papers in the group 'no specific disease focus' included studies on knowledge of, for example, dose calculation and prescribing errors. We excluded, however, knowledge questions related to the healthcare system; such as whether the HCP knew how to report adverse drug reactions. We excluded vaguely presented knowledge questions with terms like 'heard of', as hearing about medication does not suggest knowledge was retained, but suggests a passive recall of knowledge. Attitude questions like 'how much do you agree that medicine X is safe' were also excluded. We classified medication knowledge questions as testing knowledge about medication benefits, harms, both or on basic medication-knowledge issues (See Supporting information Table S2 ). Examples are knowledge on indications of emergency contraceptives (medication benefit), knowledge/awareness of safe period for artemetherlumefantrine use during pregnancy (medication harm), knowledge on the correct dose of specific medication (both medication benefit and harm), knowledge of different types of emergency contraceptive (basic medication knowledge).
We also extracted an excerpt of the conclusion and recommendations provided by the authors themselves.
Assessment of the quality of the included studies
We developed and pretested a nine-item tool to score the quality of the studies (See Supporting information Table S3 ). The tool contained items on representativeness of the HCP population included in the studies (sampling method, sample size, response rate and demographics), the methods used to test the HCPs' medication knowledge (clarity of the knowledge questions, definition of appropriate answers and validation of knowledge questionnaires) and finally on the presentation of results (descriptive statistics and missing data). This score was based on a modified version of the STROBE checklist [14] . The sum score of all nine items was set at 10 with a maximum score of two for one item and one point for all others. We grouped the quality into low (0 to 5), medium (>5 to 8) and high (>8) scores. These cut off values are arbitrary but commonly used limits in different scoring issues.
Outcome measure
Medication knowledge questions were extracted from each study. We computed the 'knowledge score' by dividing the sum of HCPs with a correct answer by all HCPs who completed the question. This was defined as Knowledge score per question ð Þ ¼ ∑HCPs with correct answer to the question ∑HCPs who completed the question Ã100%
We followed the definitions for a correct answer as indicated in the papers and/or cited references. We dichotomized all answers into correct or incorrect answers. If papers used a dichotomous answer (correct/incorrect, yes/no), this meant we could use the knowledge score as reported in the paper. In studies, where the numbers of respondents with a wrong answer were presented, we calculated the number of respondents with a correct answer. If answers to questions were presented on a three or more point Likert scale (e.g. low, medium or high knowledge score), we dichotomized these answers by grouping medium and high scores as correct answers. Finally, if respondents had to choose between multiple answers and there could be more than one correct answer, each answer was counted separately. In intervention studies with several measurement points, e.g. a pre-and post-training score, we extracted the pre-intervention score.
In randomized controlled trials (RCT), we used the preintervention medication knowledge score of the control group. We assumed the pre-intervention or control group reflects daily practice.
Statistical analysis
This study focused on evidence synthesis on HCPs' medication knowledge in Africa. The questions within and between papers were very heterogeneous in terms of answer categories (see above) and complexity. We therefore used descriptive statistics to explore knowledge across extracted study characteristics (Table 1 ). We hypothesized that medication knowledge may be determined by the disease focus and type (profession) of HCPs due to differences attached to relevance of drugs in a particular field of medicine. Additionally, we considered that sample size and quality of the study may affect the trust in study results. Finally, we considered that emphasis in treatment is placed on efficacy not safety and thus this could affect medication knowledge on harms caused by drugs.
Results
Study characteristics
Of 2379 potentially relevant publications, 64 papers met our inclusion criteria, based on respectively screening of the title (n = 2379), abstract (n = 447) and full text (n = 185) ( Figure 1 ). Three papers identified for full-text screening had to be excluded as we could not get hold of these papers even after repeated attempts to reach the authors. Overall, 13 911 HCPs ranging from 16 to 2386 (median 176) HCPs per paperanswered a total of 306 medication-related knowledge questions. In total, 5011 nurses/midwifes, 4892 physicians, 1455 pharmacists and 1721 other HCPs were included in respectively 37 (58%), 38 (59%), 20 (31%) and 26 (41%) papers. Three papers mentioned the type of HCPs, but did not provide group specific numbers and two papers did not specify the type of HCPs involved in the study. The studies have been performed in 12 African countries, but 75% originated from four countries: Nigeria (n = 29 papers), Tanzania (n = 9), Kenya (n = 6) and Cameroon (n = 4) ( Tables 1 and 2 ). Most knowledge questions (n = 215; 70%, 45 papers) were on communicable diseases, followed by 33 (11%, eight papers) questions on non-communicable diseases, 31 (10%, five papers) questions on family planning and gynaecology, and 27 (10%, 6 papers) questions with no specific disease focus. The majority (n = 116; 38%) of knowledge questions were on medication benefit, the remainder of the questions were equally on medication harm (20%), both benefit and harm (24%), or related to basic medication knowledge (19%) (see Table 1 ).
Study quality
All but three of the studies were descriptive cross-sectional surveys. Two studies assessed the impact of training or a workshop and had pre-and post-intervention knowledge scores [15, 16] and one study was a randomized controlled trial [17] .
The mean quality score of the papers was 7.5 (SD 1.8, range 3-10). The included papers scored poorly with regard to sample size calculation (item 1), sampling methods (item 2) and tool validation (item 7 of our quality score tool). In all papers, information was collected via interviews or self-administered questionnaires. Two papers [18, 19] used mystery client surveys, in addition to interviews. In most papers (n = 53), questionnaires were newly developed by the authors, of which four followed a 'formal' validation procedure, 28 conducted only a pre-test, and 21 papers did not explain if or how the questionnaire was validated. The remaining 11 papers adapted a tool previously used by others; five used an adapted tool and six made some modifications ( Table 2 ). Most papers defined how the medication knowledge score was measured (item 5, n = 60) (see Table 3 ).
Medication knowledge questions and scores
Overall, 306 medication-related knowledge questions were identified; a median of four (range 13 and interquartile range 6) questions per paper. Fifty-two percent (SD 28) of HCPs answered the 306 questions correctly. Physicians answered a mean of 56% (SD 31) out of 107 questions correctly, nurses/midwifes 55% (SD 32) out of 89 questions, pharmacists 49% (SD 31) out of 55 questions, and other HCPs 52% (SD 35) out of 39 questions ( Table 1 ).
The highest proportion of correct answers (68%, SD 23) was reported in South African studies and the lowest in Zimbabwean studies with (37%, SD 7) correct answers; more detailed results are presented below and in Table 2 .
The highest knowledge scores were observed for questions on basic medication knowledge (59%, SD 27) and questions on both benefit-harm issues (59%, SD 27), which were higher than questions on benefits (49%, SD 28) and harm (41%, SD 27) only. questions; for a number of questions sometimes results were reported for mixed groups of HCPs. For example, physicians answered 175 questions but only 107 of these results were reported separately for this group of professionals c We split (equal tertiles) papers based on their sample size Other HCPs, druggists/pharmacy technicians, nurse assistants/vocational nurses, or physiotherapists; Others (for disease), did not have a specific disease focus, including dose calculation and prescribing errors; HCP, healthcare professional
Figure 1
Review process There is high awareness of the vaccine but more education is required to further increase nurses' willingness to recommend the vaccination. 
(continues)
Finally, papers that had the lowest quality scores reported higher medication knowledge by HCPs than the studies with medium or high quality.
Disease focus
Communicable diseases (215 questions, 45 papers). The majority of papers and medication-related knowledge questions were for medicines used for malaria, HIV/AIDS, tuberculosis and for vaccines.
Forty-eight questions in 11 papers queried HCPs about their medication knowledge to treat or prevent malaria [17, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] . These questions identified knowledge gaps across all aspects of antimalarial medication use; i.e. dosing, drug-drug (food) interactions, contraindications, appropriate use in specific patient groups (paediatrics, pregnancy and adults). The main finding, as reported by authors, was the lack of knowledge on rational and effective use of artemisinin-based combination therapy and implementation of recommended intermittent preventive treatment in pregnancy or medications for specific age groups.
Forty-seven questions in nine papers were on antiretroviral medications for HIV/AIDS [30] [31] [32] [33] [34] [35] [36] [37] [38] . In these papers, it is reported that HCPs lacked knowledge on use of microbicides Tool (questionnaires) validation: a Self-made with expanded/formal validation process, b Self-made with pretest only, c Cited previous developed tool and used as such, or d Cited previously developed tool with modification, and e Self-made without clear explanation for validation
On the overall score, papers without standard deviation are these with only one knowledge question HCPs: healthcare professionals; P: physician, PM: pharmacist, N/M: Nurse midwife, O: Other HCP; ACT; Artemisinin-based Combination Therapy, IPTp; Intermittent Preventive Therapy in pregnancy (malaria chemoprevention in pregnancy), ADR; adverse drug reaction, OTC; Over-the-counter, DM; diabetes mellitus, PMTCT: Prevention of mother-to-child transmission to prevent HIV and other sexually transmitted diseases, that they were unable to identify medications used for postexposure prophylaxis (PEP), and did not know the time point to initiate PEP, duration of treatment and effectiveness of PEP. The main finding in these papers was that PEP was underused, and it was speculated that this was partly due to the low level of PEP-related knowledge. Forty-eight questions were about different types of vaccines; 23 on hepatitis B [39] [40] [41] [42] [43] , eight on human papilloma virus [44] [45] [46] , three on influenza [47, 48] viruses, and 14 questions on adverse events following immunization [49] . Questions were about overall awareness of different types of vaccines, and the effectiveness, what comprised a dose/full course, how long the vaccines offered protection, and about the safety of vaccination, adverse reactions after immunization, and medication used to prevent/relieve vaccinationrelated immune reaction. The papers on hepatitis B reported overall good knowledge of the vaccine (56-97%), but despite this good knowledge, HCPs' perceived benefit and actual use of the vaccine was low. All but one paper reported poor knowledge of vaccines for human papilloma and influenza viruses, and also about adverse reactions following immunization.
Fourteen questions from four papers were on knowledge of medication used to treat tuberculosis [50] [51] [52] [53] , focusing on child tuberculosis treatment, knowledge of the complex treatment regimens (number of medications, duration of therapy and safety concerns), and about the consequences of poor treatment adherence. Two of these papers reported poor knowledge on tuberculosis treatment regimens and consequences of medication non-compliance.
The remaining 58 questions in papers focusing on medications for communicable diseases were about medications for human African trypanosomiasis, anti-diarrheal agents, sepsis management, general antimicrobial indications, safety or resistance [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] . Topics in these papers were timing of administration and safety issues of perioperative antibiotic prophylaxis, prevention of antimicrobial resistance and contributing factors, inappropriate antibiotic prescribing, and diarrhoea management in children. The main findings from these papers were that HCPs had a fair knowledge of what constitutes rational antimicrobial use, but poor knowledge of antimicrobial resistance and especially on products for diarrhoea.
Non-communicable diseases (38 questions; 8 papers).
Medication questions on non-communicable diseases concerned cancer treatment and cancer-related pain management and palliative care in two papers (n = 12), medications for asthma/COPD (n = 12) in three papers, four on management of thyroid cancer and use of radioactive iodine in one paper, and finally three papers on antipsychotics [15, [64] [65] [66] [67] [68] [69] [70] . The main knowledge questions were more general, as the papers focused mostly on general disease management and type of medication to be used. The main findings were knowledge gaps on palliative care, use of radioactive iodine for thyroid cancer, long active long-acting antipsychotic injections, asthma/COPD and cancer pain management.
Family planning and gynaecology (31 questions; 5 papers). Thirty-one questions in five papers were about contraceptives or medication used in gynaecological procedures [19, [71] [72] [73] [74] . The knowledge questions were about appropriate use of medication for (pre-)eclampsia, neonatal resuscitation, emergency contraceptives (type, dose, indication, side effects and time window for use), and abortifacient medication use and complications. The studies reported limited knowledge on medical abortion, pharmacotherapeutics of oral and emergency contraceptives. Many papers indicated also important attitudinal issues affecting the proper use of especially emergency contraceptives and abortifacients.
Without specific disease focus (27 questions; 6 papers). Six papers (14%) with 27 medication-related knowledge questions did not have a specific disease focus (grouped under 'other' in Table 2 ) [16, 18, [75] [76] [77] [78] . Questions were more general including self-medication, topical medications (antipain and antibiotics), dose calculation and prescribing errors. Authors reported this type of general knowledge to be poor as with other disease groups. In particular, there was low level of knowledge on self-medication practices, prescribing errors and pharmacotherapy of dermatological products.
Discussion
We provide a comprehensive overview of medication knowledge based on a review of 64 papers including 13 911 HCPs from 12 African countries. Overall, 52% (SD 28) of HCPs answered a total of 306 knowledge questions correctly. Physicians, nurses and midwives were most often included, but pharmacists were also well represented. Most (70%) studies were about communicable disease medications including antimalarial, antiretroviral medications for HIV, and different types of vaccines. The large majority of included studies were of medium to high quality but especially validation of the questionnaire was either poorly performed or described. Most papers reported as a main finding that HCP lacked sufficient medication knowledge and needed training to improve this knowledge.
Medication knowledge
Our paper shows that, using a systematic approach, it is possible to synthesize a comprehensive overview of medication knowledge from papers that may have a wider scope, e.g. focusing on overall disease management. The overall knowledge score of 52% shows that medication knowledge continues to be a problem. The issue seems generic for all medicines across different disease areas, as medication knowledge questions were answered relatively similarly between different disease areas. Although there is no universally accepted threshold to define adequate knowledge, we think that the score found in our study is suboptimal considering the pass mark (60%) often used in medical colleges or in educational practice in general. Most papers concluded that knowledge was suboptimal despite the fact that no paper had a predefined acceptable knowledge score. Knowledge is also lower in comparison with a study conducted in 15 countries in Europe (70%), two studies in Norway (score > 60%), and one study performed in The Netherlands (score > 70%) [1, 3, 4, 6] . Observed medication knowledge deficits among HCPs in our study may be explained by a lack of adequate drug information resources and up-to-date reference books, limited access to internet (mainly outside the main cities), and due to lack of integration of (clinical) pharmacology courses with major professional courses in under-and postgraduate courses. Pharmacology courses are often delivered early in the study curriculum, before professional courses (internships) specifically for physicians and nurses take place. This makes it difficult to integrate medication knowledge and clinical skills. An attractive scenario would be to test whether building 'personal formularies' during formal training of HCPs would increase medication knowledge, and whether sufficient attention is paid also to prescribing skills, which would result in more rational prescribing [79] . The comparison with the above studies should be made cautiously as the papers in our study covered a much broader range of topics, a wider variety of medication knowledge questions, had different study designs, different types of HCPs included and an emphasis on medication-related knowledge questions in the area of communicable diseases. Our results suggest that (clinical) pharmacology and therapeutics education may have to be strengthened in Africa.
According to Brinkman et al. [4] , the way (clinical) pharmacology and therapeutics are taught greatly influences prescribing competence. They showed that knowledge was significantly higher among students who attended schools using problem-based or mixed-learning methods than those attending traditional learning curricula. Moreover, they also showed that factual knowledge alone had a weak correlation with prescribing skills [80] . The 'six steps' approach advocated in the 'Guide to good prescribing' adopted by the WHO, which is widely used in medical training programmes around the globe [81] , could be a good start for this. The European Association of Clinical Pharmacology and Therapeutics presented in a recent study a blueprint for a core curriculum to assure prescribing competency in Europe. This programme may not be translated in full to the African situation, but some teaching methods such as role-playing sessions, case-based discussion groups and student run clinics may work well [82] . Additionally, electronic tools like mobile apps may help HCPs maintaining and updating medication knowledge [17] . Strengthening drug information services may be another way to improve medication knowledge.
Disease focus
It is not surprising that most of the articles in our review were about medications to treat or prevent communicable diseases. These diseases present the major health challenge in Africa [83] . The reported lack of knowledge on various aspects of rational medication use and drug resistance challenges effective prevention and eradication programmes. The most discussed issues included malaria, in particular the use of artemisinin-based combinations and Prevention of Mother to Child Transmission (PMCT), HIV, especially PEP, and vaccinations.
Another area that was well studied was vaccines, where we observed knowledge gaps for different types of vaccines for hepatitis B (HBV), influenza and human papilloma viruses (HPV). Awareness of available HBV vaccines in our study (56-97%) was in line with a previous report [84] . Cervical cancer caused by human papillomavirus (HPV) is the leading cause of cancer mortality among women in Africa [85] . Although the general population in the region has some knowledge of HPV and may be quite willing to get vaccinated [86] , the knowledge deficit on the efficacy and safety of the vaccines reported in our study for HCPs needs to be addressed before they are likely to support and engage in effective vaccination campaigns. Other studies on communicable diseases were on rational antimicrobial medication use and resistance, highlighting the known antibiotic use challenges that need training and continuous education of HCPs.
Even though the burden of NCDs, such as hypertension, diabetes mellitus, asthma/COPD, stroke and cancer are increasing in Africa, relatively little attention is still paid to these diseases by health policy makers [87, 88] . It is therefore not surprising to see also few medication knowledge studies for these diseases. Of the NCDs, cancer and asthma/COPD were most widely studied, which are diseases with complex medical treatments that require high levels of HCP knowledge and skills.
In developing nations, including the majority of African countries, contraceptive use remains low with obvious consequences for population growth and thus with a high unmet need for improved family planning activities [88] . One of the major barriers reported for low use of family planning is inadequate knowledge about contraceptive methods and how to use these in the general population [89, 90] . Three papers included in our study substantiate these findings [71, 73, 91] . Due to cultural, religious and social influences, the role of HCPs is crucial for improving the uptake of contraceptives. Interventions to improve HCPs' knowledge may help to achieve the sustainable development goal 3 (reduce child mortality and improve maternal health) set by the United Nations [92] . The papers included in our study also suggest that attitudinal issues need to be overcome among HCPs.
Medication benefit versus harm aspect
In our study, most of the knowledge questions were on medication benefit. Our study suggests that the harmful aspects of medication use receive little attention, even in research. In line with this, adverse drug reaction reporting from sub-Saharan Africa is the lowest in the world [93, 94] .
Strengths and limitations
To the best of our knowledge, this is the first study of this type in Africa that provides a comprehensive overview of HCPs' medication knowledge. We used a semi-quantitative approach to facilitate a global interpretation of the large amount of published data. Our review revealed a wide range of medication and disease topics across studies. The pooled estimates should thus be interpreted with caution as the studies were highly heterogeneous, reporting a wide range of diseases that used various measuring tools. The emphasis in this paper is on descriptive rather than quantitative differences in medication knowledge.
Another limitation of this study was that our quality score assessment tool was not validated. The tool was selfdeveloped, and although it is based on the STROBE checklist, pre-tested and highly intuitive, different cut-offs or weights attached to assessment criteria could have resulted in small differences in the classification of study quality. The emphasis in this paper is therefore on a textual description of medication knowledge and general areas for improvement that should not be driven by a specific knowledge score value. In almost all papers in our review, knowledge was measured using paper-based surveys, i.e. studies did not look at prescribing practices or outcomes. The difference between paper-based knowledge scores and practical skills need to be further explored in African settings.
We did not check systematically the references of included papers for potential additional relevant studies. We think, however, this would have only minimally changed our findings, as we already included an eclectic sample of studies into HCPs' medication knowledge. Our search was limited to a five-year period (2012-2016), it allowed us to focus on studies that reflect the current situation with respect to HCPs' medication knowledge. It also allowed us to maintain a broad focus of HCP medication knowledge across disease areas, while curbing the already large number of retrieved studies.
Conclusion
Overall, our study indicates there continues to be a considerable lack of knowledge about medication in the African region. Our study suggests that there is a general need to improve education and continuous training of HCPs about medication. In particular, revised teaching methods for under-and postgraduate students may be used to improve prescribing competency. Electronic tools such as health apps may be used to provide knowledge at time of prescribing. This indicates a continued need to improve the situation, for example by paying more attention in the education system and on-the-job training. In addition, more information is needed on the effects of better knowledge on the quality of prescribing and medication use, and in the ultimate effects on health outcomes. It is also important to set up a system for monitoring HCP training programmes. 
Supporting Information
Additional supporting information may be found online in the Supporting Information section at the end of the article.
http://onlinelibrary.wiley.com/doi/10.1111/bcp.13746/suppinfo 
